Drug Type Autologous CAR-T |
Synonyms B7H3 specific CAR T cell with IL-7Ra signaling domain, B7H3 With IL-7 Receptor Alpha Signaling Chimeric Antigen Receptor T Cell, CDM03 CAR T Cell(University of Chulalongkorn) |
Target |
Mechanism CD276 modulators(CD276 antigen modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Relapsed Solid Neoplasm | Phase 1 | TH | 01 Dec 2024 | |
Diffuse Intrinsic Pontine Glioma | Phase 1 | TH | 01 Mar 2024 |